US$ 25.86
glp-1 elevated liver enzymes Multiple target tissue effects of analogues on non-alcoholic fatty disease (NAFLD) and non-alcoholic steatohepatitis (NASH) GLP-1 and Its Role in
Description
H., Brown-Frandsen K., Kristensen P., Mann J

For instance, exenatide 10 g administered twice daily has a significantly higher probability of producing nausea compared to exenatide 5 g twice daily (OR: 2.28) and exenatide once-weekly formulations (OR: 2.78)

One of the best ways to tackle this is by working closely with a medical professional and making thoughtful dose adjustments
And its unpredictable
